Targeting the CLK2/SRSF9 splicing axis in prostate cancer leads to decreased ARV7 expression by Jasper Van Goubergen, Miroslav Peřina, Florian Handle, Elisa Morales, Anika Kremer, Oliver Schmidt, Glen Kristiansen, Marcus V. Cronauer, Frédéric R. Santer

“…In advanced prostate cancer (PC), in particular after acquisition of resistance to androgen receptor (AR) signaling inhibitors (ARSI), upregulation of AR splice variants compromises endocrine therapy efficiency. …”
Get full text

The diagnostic performance of indocyanine green for the sentinel node biopsy in prostate cancer: A systematic review and meta-analysis by Siyang Ma, Jianxuan Sun, Jinzhou Xu, Ye An, Mengyao Xu, Chenqian Liu, Sihan Zhang, Lintao Miao, Xingyu Zhong, Na Zeng, Haodong He, Shaogang Wang, Qidong Xia

Subjects: Get full text

A prospective comparison of implant quality between suture-coated seeds and uncoated seeds in prostate cancer brachytherapy by Makoto Nakiri, Naoyuki Ogasawara, Hirofumi Kurose, Kosuke Ueda, Hiroki Suekane, Katsuaki Chikui, Kiyoaki Nishihara, Keiichiro Uemura, Kazuhisa Ejima, Ryuji Hoshino, Satoshi Onishi, Keisuke Komiya, Koichiro Muraki, Chikayuki Hattori, Etsuyo Ogo, Tatsuya Ishitake, Tsukasa Igawa

Subjects: Get full text

Awareness of prostate cancer and its screening tests in men in the Middle East: A systematic review and meta-analysis by Nawaf S.A. Mohamed, Joud M.O. Asfari, Samar M.A. Sambawa, Rima M.D. Aljurf, Kholoud A.A. Alsaygh, Assad M. Arafah

Subjects: Get full text

Predicting the risk of bone metastases in patients with newly diagnosed prostate cancer - Development and validation of a nomogram model. by Wei Xu, Guoyu Zhu, Xiaoxiang Wang, Xuebing Yan, Fujun Wang, Shanyi Li, Wenji Li

“…<h4>Objectives</h4>The aim of this study was to develop and validate a nomogram model that predicts the risk of bone metastasis (BM) in a prostate cancer (PCa) population.<h4>Methods</h4>We retrospectively collected and analyzed the clinical data of patients with pathologic diagnosis of PCa from January 1, 2013 to December 31, 2022 in two hospitals in Yangzhou, China. …”
Get full text

External beam radiation therapy versus radical prostatectomy for high-risk prostate cancer: protocol of the RECOVER study by Caroline M. van der Starre, Chris H. Bangma, Maarten J. Bijlsma, Alfons C.M. van den Bergh, Lambertus A.L.M. Kiemeney, Wietske Kievit, Kees Vos, Diederik M. Somford, Sally M. Wildeman, Katja K.H. Aben, Igle J. de Jong, Floris J. Pos, Berdine L. Heesterman

Subjects: “…Prostate cancer…”
Get full text

High Intensity Focused Ultrasound versus Brachytherapy for the Treatment of Localized Prostate Cancer: A Matched-Pair Analysis by Fouad Aoun, Ksenija Limani, Alexandre Peltier, Quentin Marcelis, Marc Zanaty, Alexandre Chamoun, Marc Vanden Bossche, Thierry Roumeguère, Roland van Velthoven

“…To evaluate postoperative morbidity and long term oncologic and functional outcomes of high intensity focused ultrasound (HIFU) compared to brachytherapy for the treatment of localized prostate cancer. Material and Methods. Patients treated by brachytherapy were matched 1 : 1 with patients who underwent HIFU. …”
Get full text

Development and Validation of an MRI‐Based Radiomics Nomogram to Predict the Prognosis of De Novo Oligometastatic Prostate Cancer Patients by Wen‐Qi Liu, Yu‐Ting Xue, Xu‐Yun Huang, Bin Lin, Xiao‐Dong Li, Zhi‐Bin Ke, Dong‐Ning Chen, Jia‐Yin Chen, Yong Wei, Qing‐Shui Zheng, Xue‐Yi Xue, Ning Xu

Subjects: Get full text

The Weight of HLA-DPA1 rs3077 Single Nucleotide Polymorphism in Prostate Cancer, a Multicenter Study by Mohammed Jayed Alenzi, Amany A. Ghazy, Diaa-Eldin Taha

“…Prostate Cancer…”
Get full text

Medication related osteonecrosis (MRONJ) in the management of CTIBL in breast and prostate cancer patients. Joint report by SIPMO AND SIOMMMS by Francesco Bertoldo, Cristina Eller-Vainicher, Vittorio Fusco, Rodolfo Mauceri, Jessica Pepe, Alberto Bedogni, Andrea Palermo, Umberto Romeo, Giuseppe Guglielmi, Giuseppina Campisi

Subjects: Get full text

Prognostic significance of the logistic regression model for assessing the risk of recurrence in patients with prostate cancer after radical prostatectomy by S. A. Reva, A. V. Arnautov, O. A. Klitsenko, S. B. Petrov

Subjects: Get full text

Functional interaction between receptor tyrosine kinase MET and ETS transcription factors promotes prostate cancer progression by Elisa Carouge, Clémence Burnichon, Martin Figeac, Shéhérazade Sebda, Nathalie Vanpouille, Audrey Vinchent, Marie‐José Truong, Martine Duterque‐Coquillaud, David Tulasne, Anne Chotteau‐Lelièvre

Subjects: Get full text

Investigating the Expression of c-Myc and BIRC5 in TRAIL and PBOX-15 treated Metastatic Prostate Cancer Cells by Corinne Kai Leng Chew, Hannah O'Toole, Daniela M Zisterer, Seema M. Nathwani, Jade K. Pollock

Subjects: “…metastatic prostate cancer…”
Get full text

High-Intensity Focused Ultrasound (HIFU) Focal Therapy for Localized Prostate Cancer with MRI-US Fusion Platform by Chi-Hang Yee, Peter Ka-Fung Chiu, Jeremy Yuen-Chun Teoh, Chi-Fai Ng, Chi-Kwok Chan, See-Ming Hou

“…Two patients, one from each group, eventually underwent radical treatment because of the presence of clinically significant prostate cancer in the form of out-of-field recurrences during follow-up biopsy. …”
Get full text

Radiopharmacokinetic modelling and radiation dose assessment of 223Ra used for treatment of metastatic castration-resistant prostate cancer by Vera Höllriegl, Nina Petoussi-Henss, Kerstin Hürkamp, Juan Camilo Ocampo Ramos, Wei Bo Li

“…Abstract Purpose Ra-223 dichloride (223Ra, Xofigo®) is used for treatment of patients suffering from castration-resistant metastatic prostate cancer. The objective of this work was to apply the most recent biokinetic model for radium and its progeny to show their radiopharmacokinetic behaviour. …”
Get full text

CPSF1 inhibition promotes widespread use of intergenic polyadenylation sites and impairs glycolysis in prostate cancer cells by Kiel T. Tietz, Braedan M. McCluskey, Conor R. Miller, Yingming Li, Sarah A. Munro, Scott M. Dehm

“…Summary: Localized prostate cancer can be cured by radiation or surgery, but advanced prostate cancer continues to be a clinical challenge. …”
Get full text

Celiac and Perigastric Lymph Node Metastasis of Prostate Cancer Diagnosed with Endoscopic Ultrasound-Guided Fine-Needle Aspiration by Tan Attila, Reva Ricketts-Loriaux, David A Sauer, Douglas O Faigel

“…To our knowledge, the present report describes the first case of celiac and perigastric lymph node metastasis of prostate cancer diagnosed with endoscopic ultrasound-guided fine-needle aspiration.…”
Get full text

Oral Cyclophosphamide for Patients With Metastatic Castration-Resistant Prostate Cancer in a Scenario of Limited Health Care Resources by Diana del Cisne Pineda, Gabriel Berlingieri Polho, Yumi Ricucci Shinkado, Gustavo Alves Contado, Nathalia de Souza Crusoe, Vivian Naomi Horita, Joao Carlos Resende, Jamile Almeida Silva, Guilherme Fialho de Freitas, David Queiroz Muniz, Caio V. Suartz, Leopoldo Alves Ribeiro-Filho, Paulo M. Hoff, José Mauricio Mota

“…The most common regimen (95%) was 100 mg once daily 21 days on, 7 days off. At prostate cancer diagnosis, the median age was 64.4 years (IQR, 59.4-70.8), 61.9% had metastatic de novo disease, and 55.5% had Gleason ≥8. …”
Get full text

Association between the expression of specific microRNAs and prostate cancer progression- a systematic review and meta-analysis by Jihad Awadallah Alrehaili

Subjects: Get full text

The association between the interval from biopsy to radical prostatectomy and biochemical recurrence in patients with intermediate- and high-risk prostate cancer by Carolin Siech, Mike Wenzel, Georgina Knoblich, Cristina Cano Garcia, Clara Humke, Felix Preisser, Miriam Traumann, Luis A. Kluth, Felix K. H. Chun, Philipp Mandel, Philipp Mandel

Subjects: Get full text